Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Casi Phrmactcls Inc (CASI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 511,672
  • Shares Outstanding, K 86,140
  • Annual Sales, $ 0 K
  • Annual Income, $ -10,770 K
  • 36-Month Beta 0.82
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 8.20

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.19 +14.45%
on 06/13/18
8.05 -26.17%
on 05/16/18
-2.04 (-25.56%)
since 05/15/18
3-Month
3.10 +91.61%
on 03/20/18
8.42 -29.45%
on 05/04/18
+2.73 (+85.05%)
since 03/15/18
52-Week
0.91 +552.75%
on 06/20/17
8.42 -29.45%
on 05/04/18
+5.00 (+531.91%)
since 06/15/17

Most Recent Stories

More News
Detailed Research: Economic Perspectives on CASI Pharmaceuticals, Energy Transfer Partners, Cypress Semiconductor, Xcel Energy, Ironwood Pharmaceuticals, and KalVista Pharmaceuticals -- What Drives Growth in Today's Competitive Landscape

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of CASI Pharmaceuticals, Inc....

ETP : 18.49 (-3.40%)
KALV : 7.86 (-1.13%)
IRWD : 18.44 (-0.75%)
CY : 17.89 (+1.13%)
CASI : 5.94 (+5.51%)
XEL : 43.33 (+1.07%)
New Report Released on Growing Biotech Sector

FN Media Group Presents Microcapspeculators.com News Commentary

DRNA : 12.74 (-0.86%)
PPCHD : 1.2000 (+20.00%)
IONS : 46.57 (-1.65%)
PPCB : 0.0650 (-3.85%)
CASI : 5.94 (+5.51%)
INSM : 26.73 (-5.41%)
CASI Pharmaceuticals Provides Update On EVOMELA®

CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to bringing high quality, cost-effective pharmaceutical products and innovative oncology therapeutics to patients, announces...

CASI : 5.94 (+5.51%)
CASI Pharmaceuticals To Present At The H.C. Wainwright Global Life Sciences Conference

CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to bringing high quality, cost-effective pharmaceutical products and innovative oncology therapeutics to patients, announces...

CASI : 5.94 (+5.51%)
CASI Pharmaceuticals Announces Fourth Quarter And Full Year 2017 Financial Results

CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to bringing high quality, cost-effective pharmaceutical products and innovative oncology therapeutics to patients, today...

CASI : 5.94 (+5.51%)
Today's Research Reports on Trending Tickers: Arena Pharmaceuticals and CASI Pharmaceuticals

NEW YORK, NY / ACCESSWIRE / March 21, 2018 / Stock markets rallied Tuesday on gains from the energy and consumer discretionary sector. Wall Street appears to be eagerly awaiting details from the Federal...

CME : 169.83 (+0.57%)
ARNA : 49.47 (-0.32%)
CASI : 5.94 (+5.51%)
CASI Pharmaceuticals Announces $50 Million Private Placement To Prepare Company For Commercialization In China

CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to bringing high quality, cost-effective pharmaceutical products and innovative oncology therapeutics to patients, announces...

CASI : 5.94 (+5.51%)
Factors of Influence in 2018, Key Indicators and Opportunity within Cypress Semiconductor, Abaxis,Inc, Universal Health Services, CASI Pharmaceuticals, Energy Transfer Partners, and Arconic -- New Research Emphasizes Economic Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Cypress Semiconductor Corporation...

ETP : 18.49 (-3.40%)
UHS : 115.48 (+0.78%)
CY : 17.89 (+1.13%)
ABAX : 83.26 (-0.13%)
ARNC : 17.53 (-2.61%)
CASI : 5.94 (+5.51%)
CASI Pharmaceuticals to Present at the BIO CEO & Investor Conference

CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to bringing high quality, cost-effective pharmaceutical products and innovative oncology therapeutics to patients, announces...

CASI : 5.94 (+5.51%)
Wired News - CASI Pharma Purchased abbreviated new drug applications Portfolio from Sandoz

LONDON, UK / ACCESSWIRE / January 30, 2018 / Active-Investors.com has just released a free research report on CASI Pharmaceuticals, Inc. (NASDAQ: CASI). If you want access to this report all you need to...

CASI : 5.94 (+5.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade CASI with:

Business Summary

CASI Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the acquisition, development and commercialization of proprietary therapeutics for the treatment of cancer and other diseases for the global markets, with a focus on China. The Company's products present antiangiogenic...

See More

Key Turning Points

2nd Resistance Point 6.28
1st Resistance Point 6.11
Last Price 5.94
1st Support Level 5.67
2nd Support Level 5.40

See More

52-Week High 8.42
Last Price 5.94
Fibonacci 61.8% 5.55
Fibonacci 50% 4.66
Fibonacci 38.2% 3.78
52-Week Low 0.91

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar